Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer

Clinical trial NCT04743934 · COMPLETED

Trial details

NCT number: NCT04743934
Sponsor: Andrew McDonald
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma

Start date: 2021-07-02
Primary completion: 2025-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.